Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
Walter Reed National Military Medical Center (WRNMMC) Chemistry and Immunoassay Testing Program is a federal award for Defense Health Agency held by Roche Diagnostics Corp. Estimated value $1.2M ($1.2M obligated). Current period of performance ends Mar 13, 2025. Place of performance: BETHESDA MD. Related solicitation HT001424R0007.
Walter reed national military medical center (wrnmmc) chemistry and immunoassay testing program. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Mar 13, 2025 (587 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT001424F0073? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001424F0073?
HT001424F0073 (WRNMMC and) is a Defense Health Agency award with a potential value of $1.2M, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0014-24-F-0073?
HT0014-24-F-0073 is the dashed form of PIID HT001424F0073 (WRNMMC and), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT001424F0073?
Defense Health Agency awarded HT001424F0073 to Roche Diagnostics Corp (potential $1.2M).
Who is the incumbent on HT001424F0073?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Mar 13, 2025.
When does Roche Diagnostics Corp’s HT001424F0073 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 13, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT001424F0073? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.